TOP 5 INSIGHTS IN DRUG FORMULATION AND DELIVERY
JULY EDITION
|
|
|
|
In this article, Fran DeGrazio explains why innovation in drug delivery technologies may not need to be revolutionary, but will no doubt need patient adoption, payor support, and regulatory follow-on to become sticky in the marketplace.
|
|
|
|
In this episode of Sit and Deliver, host Tom von Gunden talks with CEO Adam Mendelsohn of Vivani Medical about enhancing patient adherence and convenience via long-acting, controlled release implants delivering medications for chronic conditions.
|
|
|
|
This scientific article presents a summary of the formulation development strategy of a JAK1 inhibitor extended-release tablet, with a focus on experimental design, data interpretation, and formulation decision-making.
|
|
|
|
In Curia's series on pre-filled syringes, explore five key ways this delivery format is enhancing patient outcomes, not just through the medicine it contains, but through the device design itself.
|
|
|
|
Halo Biosciences is building a pipeline based on novel insights into how extracellular matrix dysregulation drives disease. We caught up with its leaders to discuss their approach to drug targeting and early development.
|
|
|
|